Page last updated: 2024-08-22

tranylcypromine and Cardiomyopathy, Dilated

tranylcypromine has been researched along with Cardiomyopathy, Dilated in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bottlender, R; Erfurth, A; Hoff, P; Möller, HJ1

Other Studies

1 other study(ies) available for tranylcypromine and Cardiomyopathy, Dilated

ArticleYear
[Mianserin-induced hypertension 2 weeks after discontinuation of tranylcypromine].
    Der Nervenarzt, 1997, Volume: 68, Issue:7

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cardiomyopathy, Dilated; Depressive Disorder; Drug Administration Schedule; Heart Block; Humans; Hypertension; Male; Mianserin; Middle Aged; Recurrence; Risk Factors; Substance Withdrawal Syndrome; Tranylcypromine

1997